EC Number   |
IC50 Value |
IC50 Value Maximum |
Inhibitor |
Reference |
|---|
    1.1.1.213 | 0.0004 |
- |
Phenolphthalein |
AKR1C4-selective inhibitor, in vitro and in vivo inhibition, IC50: 0.0004 mM |
675595 |
| 1.1.1.213 | 0.000735 |
- |
indomethacin |
competitive, IC50 for reduction of 9,10-phenanthrenequinone by NADPH at pH6.0 is 0.000735 mM |
347982 |
| 1.1.1.213 | 0.00084 |
- |
2-[[(3-hydroxyphenyl)carbonyl]amino]-5-nitrobenzoic acid |
pH 7.0, temperature not specified in the publication |
724538 |
| 1.1.1.213 | 0.0019 |
- |
5-bromo-2-[[(3-hydroxyphenyl)carbonyl]amino]benzoic acid |
pH 7.0, temperature not specified in the publication |
724538 |
| 1.1.1.213 | 0.0022 |
- |
5-chloro-2-[[(3-hydroxyphenyl)carbonyl]amino]benzoic acid |
pH 7.0, temperature not specified in the publication |
724538 |
| 1.1.1.213 | 0.0024 |
- |
naringenin |
- |
697265 |
| 1.1.1.213 | 0.0027 |
- |
naproxen |
synthetic, nonsteroidal anti-inflammatory inhibitor, in vivo IC50: 0.0094 mM in fluorometric assay, 0.016 mM in radiometric assay, in vitro IC50: 0.0027 mM in fluorometric assay |
676812 |
| 1.1.1.213 | 0.00333 |
- |
indomethacin |
competitive, IC50 for oxidation of androsterone by NAD+ at pH 7.0 0.00333 mM |
347982 |
| 1.1.1.213 | 0.0049 |
- |
7-hydroxyflavone |
- |
697265 |
| 1.1.1.213 | 0.0052 |
- |
2-[[(3-hydroxyphenyl)carbonyl]amino]-4,5-dimethoxybenzoic acid |
pH 7.0, temperature not specified in the publication |
724538 |
